Piotr Szcześniak

Neopterin as a marker of cellular immunological response

Neopterin is a pyrazino-pyrimidine compound that belongs to the pteridine group. It is known to be a biochemical marker associated with cell-mediated immunity. It is produced by human monocytes/macrophages and dendritic cells from guanosine triphosphate (GTP) upon stimulation with interferon gamma (IFNγ), which is released by activated limphocytes Th. Neopterin is a very important clinic parameter, though the physiological role has not been exactly definited thus far. The level of neopterin reflects the stage of activation of the cellular immune system, which is important in the pathogenesis and progression of various diseases. Measuring its concentration in body fluids is used in many different areas of modern medicine, such as infectious disease, gastroenterology, transplantology and transfusiology, rheumatology or oncology. In neurological, cardio-vascular and autoimmune diseases, cell-mediated immunity is also activated, which is proved by the elevated level of this marker. Measurements of neopterin concentrations are also helpful in monitoring the therapy of patients infected with the HIV virus or treated by using immunomudulating therapy. As a result of measuring levels of neopterin in patients with neoplasms of digestive tract, increased concentration was proved, but it is not routinely used in everyday clinic practice.

The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes

Introduction Irritable bowel syndrome (IBS) and celiac disease (CD) share some gastrointestinal symptoms. Celiac disease should be considered in a differential diagnosis of IBS. Aim To estimate the prevalence of predispositions to CD in patients with IBS and its subtypes. Material and methods The study included 48 patients (40 women, 8 men; average age: 41.1 ±14.6 years) with IBS, and a control group: 20 healthy volunteers. All participants completed a questionnaire on their current gastrointestinal symptoms and had a blood sample taken to determine the HLA-DQ2/DQ8 antigens and serum concentration of anti-tTG IgA and anti-DGP IgA and IgG. Results The presence of HLA-DQ2 or DQ8 was found in 50% of patients (n = 24) with IBS. In the control group the presence of HLA-DQ2 was found in 4 (20%) patients and nobody had HLA-DQ8. Increased levels of anti-tTG IgA were found in 5 (10.42%) patients with IBS, anti-DGP in 4 (8.33%), and anti-DGP IgG in 3 (6.25%). In the control group positive test result for anti-tTG was found in 2 (10%) patients; nobody had elevated anti-DGP IgA or IgG. A concomitant positive result of genetic testing and any elevated serum antibodies specific to CD was found in 12.5% of IBS patients (n = 6) and in none of the control group. Conclusions Patients with IBS, regardless of the subtype, significantly more often than healthy controls have the predisposing genetic factors (HLA-DQ2/DQ8) underlying the development of CD.

Evaluation of erythromycin concentration in the umbilical artery serum

OBJECTIVES The aim of the study was to investigate the effectiveness of erythromycin in preventing intrauterine infection caused by group B streptococcus (GBS). MATERIAL AND METHODS The study included 20 pregnant women with GBS-positive screening or whose laboratory screening was not available, who delivered between April 17, 2013 and July 22, 2013. The women were given 600 mg of erythromycin intravenously After delivery blood was drawn in parallel from maternal antecubital vein and umbilical cord artery Serum erythromycin concentrations were evaluated using enzyme-linked immunosorbent assay (ELISA) kit. Statistical analysis for measurable and non-measurable characteristics were performed, correlation coefficients for each pair of variables were calculated in order to investigate the sought dependence. RESULTS Mean placental transfer of erythromycin was 2.04%. There was a high correlation between umbilical artery serum and maternal serum erythromycin concentration. Selected variables of mothers in the control group had no effect on serum erythromycin concentration in the umbilical artery CONCLUSIONS Transplacental transfer of erythromycin is limited (2.04%). Intravenous application of erythromycin at a dose of 600 mg does not allow to achieve the value of MIC50 and MIC90 for erythromycin against strains S. agalactiae in umbilical artery serum, what suggests a compromised efficacy in the treatment of intrauterine fetal infections. At the same time, the placenta seems to be an effective barrier reducing fetal exposure when this macrolide is used to treat maternal infections.

The Assessment Of The Risk Of Allergenicity Of ‘Sabina’ And ‘Debreceni Bötermö’ Sour Cherry Cvs (Prunus Cerasus L.) In A Guinea Pig Model

Abstract The allergic reactions to fruits are lesser known among food sensitivities. The most common fruits belonging to the Rosaceae family that might cause allergic reactions are apples, pears and peaches. However, little is known about the potential allergic reactions caused by another member of the Rosaceae, the cherry. The aim of this study was to assess the risk of any allergic reaction or food hypersensitivity resulting from topical application and chronic oral administration of cherry fruits. The cherry fruits ‘Sabina’ cv. were produced in the orchard in Dąbrowice according to the principles of integrated (IFP) and organic (OR) productions. Fruits of ‘Debreceni Bötermö’ cv. were produced in Dąbrowice (IFP), and in the orchard in Nowy Dwór (OR). The experiments were performed on 65 outbred young, adult, white albinotic guinea pigs (Dankin Hartley). Three procedures were applied: I. Guinea-Pig Maximization Test (GPMT); II. Chronic administration of fruits and III. Skin prick (Dreborg) test. The skin reactions based on GPMT or Dreborg tests revealed no differences between the two cherry cultivars ‘Sabina’ and ‘Debreceni’ obtained from integrated or organic production. Similarly, it was not observed of any effect of cultivars of cherries nor the type of fruits production on the guinea pig skin reaction as a result of chronic feeding with fruits.

The background and new perspectives and agricultural aspects concerning food allergy and fruit hypersensitivity

ABSTRACT In this review, some features of fruit allergenicity including the pathophysiology, cross allergy reactions, most common allergens and novel pathways of reducing hypersensitivity reactions as far as agricultural aspects are concerned, were described. STRESZCZENIE W niniejszym artykule podjęto zagadnienia związane z alergiami pokarmowymi, w tym alergiami wywoływanymi przez owoce, ze szczególnym uwzględnieniem podłoża patofizjologicznego, występowania alergii krzyżowych, najczęstszych alergenów odpowiedzialnych za opisywane reakcje oraz kierunków działań podejmowanych w celu zmniejszenia potencjalnej alergenności owoców.